U.S. Markets close in 8 mins

VKTX or ENTA: What to Expect from Revenue Growth in 2019

Margaret Patrick
VKTX or ENTA: What to Expect from Revenue Growth in 2019

What Are Analysts Recommending for VKTX and ENTA?(Continued from Prior Part)Growth drivers In November 2018, Viking Therapeutics (VKTX) issued a press release announcing positive results from its Phase 2 trial evaluating the efficacy of the 1-mg dose